Officials will use participation as evidence that the process was inclusive and broadly supported. That claim provides procedural cover for inaction, allowing officials to present incremental adjustments as stakeholder-supported reform. The Delphi studies will be weaponised as a durable rhetorical shield against renewed scrutiny. There are options. …
Stakeholders must act to protect their voice in response to the risk of a manufactured consensus
May 7, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
GBMA White Paper calls for reforms to strengthen supply chain resilience
August 10, 2026 - - Latest News -
France the first to provide comprehensive reimbursement for GLP-1s for weight loss while Australia looks on
August 10, 2026 - -
New Zealand's ACT announces plan for pharmacies to do a lot more, but also ownership and location reform
August 10, 2026 - -
Achieving value is meaningless if it undermines access to medicines
August 10, 2026 - -
Australia’s 'Biggest Week in Biotech' brings global life sciences leaders to the Gold Coast
August 9, 2026 - - Australian Biotech -
The 'Dispatched' Podcast - Week in review
August 7, 2026 - - Podcast -
A new generation is rewriting their lives living with Cystic Fibrosis
August 7, 2026 - - Latest News